Table 2.
MET gene FISH status | |||||||
---|---|---|---|---|---|---|---|
FISH-negative | FISH-positive | p-value | |||||
Total | % | Total | % | Total | % | ||
Variables | 35 | 100 | 24 | 100 | 11a | 100 | |
Age | |||||||
<65 | 13 | 37 | 9 | 38 | 4 | 36 | |
65≦ | 22 | 63 | 15 | 63 | 7 | 64 | 1.00 |
Gender | |||||||
Male | 15 | 43 | 12 | 50 | 3 | 27 | |
Female | 20 | 57 | 12 | 50 | 8 | 73 | 0.28 |
Smoking status | |||||||
Current and former smoker | 14 | 40 | 10 | 42 | 4 | 36 | |
Never smoker | 21 | 60 | 14 | 58 | 7 | 63 | 1.00 |
Stage | |||||||
III | 4 | 11 | 3 | 13 | 1 | 9 | |
IV + Relapse | 31 | 89 | 21 | 87 | 10 | 91 | 1.00 |
EGFR mutation subtype | |||||||
Exon19 deletion | 25 | 71 | 19 | 79 | 6 | 55 | |
Exon21 L858R | 10 | 29 | 5 | 21 | 5 | 46 | 0.23 |
Response to Gefitinib | |||||||
CR + PR | 31 | 89 | 22 | 92 | 9 | 82 | |
SD + PD | 4 | 11 | 2 | 8 | 2 | 18 | 0.57 |
aHigh polysomy was observed in 10 patients (28.5%) and amplification was in 1 patients (2.9%) of 35 NSCLC patients.